No Prosecution In South Korean Co.'s Transfer Pricing Row
By Matthew Guerry · March 14, 2022, 6:36 PM EDT
South Korean regulators said they will not seek to prosecute a major biopharmaceutical company for running afoul of the country's regulations on transfer pricing, according to local media....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login